Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice

Mol Psychiatry. 2013 Oct;18(10):1053-4. doi: 10.1038/mp.2012.168. Epub 2012 Nov 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease
  • Amyloid beta-Peptides / administration & dosage
  • Amyloid beta-Peptides / pharmacokinetics
  • Amyloid beta-Peptides / toxicity*
  • Anhedonia / drug effects
  • Animals
  • Brain Chemistry / drug effects
  • Cognition Disorders / chemically induced*
  • Cognition Disorders / metabolism
  • Cytokines / analysis
  • Depression / chemically induced*
  • Depression / metabolism
  • Disease Models, Animal
  • Drinking Behavior
  • Fluoxetine / administration & dosage
  • Fluoxetine / therapeutic use
  • Gliosis / chemically induced
  • Gliosis / prevention & control
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Immobility Response, Tonic
  • Inflammation
  • Injections, Intraventricular
  • Memory Disorders / chemically induced
  • Memory Disorders / metabolism
  • Mice
  • Physical Endurance
  • Premedication
  • Recognition, Psychology / drug effects
  • Sucrose
  • Swimming

Substances

  • Amyloid beta-Peptides
  • Cytokines
  • Fluoxetine
  • Sucrose